Eli Lilly Research and Development Expenses 2010-2024 | LLY

Eli Lilly research and development expenses for the twelve months ending December 31, 2024 were $10.991B, a 18.01% increase year-over-year.

  • Eli Lilly annual research and development expenses for 2024 were $10.991B, a 18.01% increase from 2023.
  • Eli Lilly annual research and development expenses for 2023 were $9.313B, a 29.52% increase from 2022.
  • Eli Lilly annual research and development expenses for 2022 were $7.191B, a 3.75% increase from 2021.

Eli Lilly Research and Development Expenses 2010-2024 | LLY

  • Eli Lilly annual research and development expenses for 2024 were $10.991B, a 18.01% increase from 2023.
  • Eli Lilly annual research and development expenses for 2023 were $9.313B, a 29.52% increase from 2022.
  • Eli Lilly annual research and development expenses for 2022 were $7.191B, a 3.75% increase from 2021.
Related Stocks
Company NameMarket
Cap
Johnson & Johnson (JNJ)$384.4B
Novo Nordisk (NVO)$375.8B
AbbVie (ABBV)$354.6B
Roche Holding AG (RHHBY)$262.5B
Merck (MRK)$221.8B
Novartis AG (NVS)$219.3B
Pfizer (PFE)$146.8B
Sanofi (SNY)$137.4B
Bayer (BAYRY)$22.6B
Innoviva (INVA)$1.1B